Veterinary

Calysta’s FeedKind Protein Receives MARA Approval for Use in Aquaculture Feeds

Retrieved on: 
Wednesday, January 31, 2024
Biotechnology, Retail, Health, Consumer, Other Science, Environment, Sustainability, Agriculture, Natural Resources, Fitness & Nutrition, Science, Veterinary, Food, Beverage, Pets, Fermentation, Research, Early, Salmon, Weather, Protein, Methane, Aquaculture

Calysta’s FeedKind® protein has received formal approval for use in aquaculture feeds in China as the company’s joint venture with Adisseo, Calysseo, prepares to deliver first product to customers through Adisseo sales network in China.

Key Points: 
  • Calysta’s FeedKind® protein has received formal approval for use in aquaculture feeds in China as the company’s joint venture with Adisseo, Calysseo, prepares to deliver first product to customers through Adisseo sales network in China.
  • The country’s Ministry of Agriculture and Rural Affairs (MARA) has formally given Calysta’s single cell protein full approval for use in fish and shrimp feeds after an extensive evaluation process.
  • It means that protein produced by Calysseo – Calysta and Adisseo’s joint venture to produce FeedKind for the Asian aquaculture market – can now be sold and used in Chinese aquaculture feeds.
  • Calysseo’s first production plant is in Chongqing, already producing sustainable FeedKind protein for the aquaculture industry, giving producers access to an alternative to plant or animal sources for aquafeed diets.

Vetster Ushers in New Era of Employee Pet Benefits with Launch of Vetster for Business

Retrieved on: 
Wednesday, January 31, 2024
Health, Consumer, Telemedicine, Virtual Medicine, Health Insurance, Pets, Veterinary, Family, Samsung, ROI, Running, Absenteeism, Workforce, Climate, Morale, Business, Roger Hawkins (drummer), Management

Vetster , the world's fastest growing veterinary telehealth and pet care marketplace, today announced the launch of Vetster for Business , the only pet health platform connecting employees with a veterinarian of their choosing - 24/7.

Key Points: 
  • Vetster , the world's fastest growing veterinary telehealth and pet care marketplace, today announced the launch of Vetster for Business , the only pet health platform connecting employees with a veterinarian of their choosing - 24/7.
  • Vetster for Business is available today starting at only $1 USD per employee per month.
  • An additional bonus for employers is the impact of Vetster for Business on improving employee happiness while simultaneously reducing employee absenteeism.
  • Vetster is the world's leading veterinary telehealth and pet care marketplace connecting pet owners with top-rated veterinary professionals.

Veterinary Practice Partners Enters into Partnership with Dr. Michelle Rudd of Annapolis Cat Hospital and Bay Ridge Animal Hospital, Expanding the Pathway to Ownership for Female and Associate DVMs

Retrieved on: 
Tuesday, January 30, 2024
Health, Veterinary, Pets, Consumer, Partnership, Environment, Patient, VPP, Marketing, Medicine, Veterinarian, Pharmacy, Woman, Female, Veterinary medicine, Culture, Dentistry, HR, Accounting, Workforce, Hospital

Veterinary Practice Partners (VPP), the veterinary community revolutionizing vet practice ownership and support, is proud to announce its partnership with Dr. Michelle Rudd, who is transitioning from associate veterinarian and Medical Director at the Annapolis Cat Hospital and Bay Ridge Animal Hospital to equity partner.

Key Points: 
  • Veterinary Practice Partners (VPP), the veterinary community revolutionizing vet practice ownership and support, is proud to announce its partnership with Dr. Michelle Rudd, who is transitioning from associate veterinarian and Medical Director at the Annapolis Cat Hospital and Bay Ridge Animal Hospital to equity partner.
  • Located in Annapolis, Maryland, the Annapolis Cat Hospital and Bay Ridge Animal Hospital originally partnered with VPP in 2017.
  • The hospitals are full-service, state-of-the-art veterinary practices, providing wellness care, diagnostics, dentistry, surgery, an in-house pharmacy, and more.
  • “VPP’s differentiated approach to partnership allows veterinarians like me to have a vested interest in the two practices,” said Dr. Rudd.

Adtalem Global Education Fiscal Second Quarter 2024 Results; Guidance Raised

Retrieved on: 
Tuesday, January 30, 2024
Nursing, Education, Mental Health, Health, Other Health, University, Veterinary, Online, Partnership, Chamberlain University, Walden University, BSN, Mental health service, Research, Substance Abuse, ATGE, Faculty, Government, Ministry, Mental health, Veterinary medicine, Adtalem Global Education, Student, Growth

Adtalem Global Education Inc. (NYSE: ATGE) today reported second quarter fiscal 2024 results (ended Dec. 31, 2023) reflecting accelerated total enrollment and revenue growth, underpinned by strong profitability and high-quality academic outcomes through executing Growth with Purpose strategy.

Key Points: 
  • Adtalem Global Education Inc. (NYSE: ATGE) today reported second quarter fiscal 2024 results (ended Dec. 31, 2023) reflecting accelerated total enrollment and revenue growth, underpinned by strong profitability and high-quality academic outcomes through executing Growth with Purpose strategy.
  • “Adtalem once again performed ahead of expectations this quarter, solidifying our position as a leading healthcare educator,” said Steve Beard, president, and chief executive officer, Adtalem Global Education.
  • “Our success was primarily driven by the continued execution of our Growth with Purpose strategy, which has yielded robust organic revenue growth, improved operational efficiencies and outstanding student outcomes.
  • Reflecting the higher level of sustainable enrollment and our confidence in our ability to continue to deliver strong top- and bottom-line performance, we are raising our fiscal year 2024 guidance.

Nu-Tek BioSciences Completes Certifications & Qualifications of Dedicated Animal-Free Peptone and Hydrolysates Manufacturing Facility to Serve Growing Supply Chain Demand

Retrieved on: 
Tuesday, January 30, 2024
Biotechnology, Manufacturing, Other Health, Health, Pharmaceutical, Health Technology, Other Science, Research, Other Manufacturing, Science, Veterinary, COVID-19, ISO 9001:2015, ISO, Interview, Peptide, Organic, Fine chemical

Nu-Tek has secured ISO 9001:2015, HALAL, Kosher, & Organic certifications and has successfully completed customer qualifications for this new facility.

Key Points: 
  • Nu-Tek has secured ISO 9001:2015, HALAL, Kosher, & Organic certifications and has successfully completed customer qualifications for this new facility.
  • This is the first dedicated, animal-free peptone, and protein hydrolysate manufacturing facility in the U.S.
  • This U.S. owned peptone manufacturing plant is helping meet the growing demand for materials used to manufacture biologics.
  • This investment provides pharmaceutical companies with solutions to mitigate supply chain risk, both current and future, with a long-term sustainable asset.

Joseph Altobelli joins Bond Vet as Chief Financial Officer

Retrieved on: 
Monday, January 29, 2024
Health, Veterinary, Other Health, Warburg Pincus, CFO, Deutsche Bank, PineBridge Investments, CityMD, Organization, Human, Merrill (company), Salomon Brothers, AIG, Growth, Management

Bond Vet, a leading provider of veterinary primary and urgent care services in the United States, proudly announces the appointment of Joseph Altobelli to the position of Chief Financial Officer (CFO).

Key Points: 
  • Bond Vet, a leading provider of veterinary primary and urgent care services in the United States, proudly announces the appointment of Joseph Altobelli to the position of Chief Financial Officer (CFO).
  • Joe joins Bond with over 20 years of experience leading Finance teams and guiding companies through phases of rapid growth, most notably at CityMD as they scaled to 160+ Urgent Care locations.
  • He previously held Controllership and Chief Financial Officer positions at industry leading organizations including PineBridge Investments, AIG, Merrill Lynch, Deutsche Bank and Salomon Smith Barney.
  • “I’m thrilled to welcome Joe to Bond Vet,” said Garrett Lewis, Chief Executive Officer.

Carson&BearTM Dog Wellness Program Launches Groundbreaking Canine Health Project Offering Help to People Who Love Their Dog

Retrieved on: 
Wednesday, January 24, 2024
Veterinary, Pets, Health, Food, Beverage, Online Retail, Consumer, Fitness & Nutrition, Retail, Research, Heart, American Kennel Club, Happiness, Dog, Pet, Bear, Human, Movement, Longevity, DVM, AKC, Doctor of Philosophy, Food industry, Parent, Veterinarian, Growth

In a launch designed to disrupt the growing and often confusing petfood market, Carson&BearTM Dog Wellness Program is introducing a transformative approach to canine health with the national unveiling of its multifaceted wellness program to help people who love their dogs.

Key Points: 
  • In a launch designed to disrupt the growing and often confusing petfood market, Carson&BearTM Dog Wellness Program is introducing a transformative approach to canine health with the national unveiling of its multifaceted wellness program to help people who love their dogs.
  • Carson&Bear’s comprehensive dog wellness and education program supports pet owners who crave facts and scientifically formulated wellness products that will extend their dog’s life.
  • Their combined creation of platform-centric technology and dog wellness products are poised to change public expectations and understanding of canine nutrition and wellness.
  • "At Carson&Bear we are not just launching a technology-based service and products for dog lovers; we are igniting a movement towards transformative canine care.

PhageLab Raises $11 Million to Develop Bacteriophage Solutions to Treat Bacterial Outbreaks in the Livestock Industry

Retrieved on: 
Tuesday, January 23, 2024
Data Management, Other Science, Technology, FDA, Research, Other Health, Pharmaceutical, Infectious Diseases, Genetics, Fitness & Nutrition, Clinical Trials, Nanotechnology, Artificial Intelligence, Biotechnology, Software, Health, Hardware, Science, Agriculture, Veterinary, Natural Resources, Bacteriophage, Livestock, Policy, Multimedia, Gastroenteritis, Collaborative Fund, Data, IPPE

PhageLab will also use the funding to expand its global team, which currently has close to 100 employees across Latin America and Europe.

Key Points: 
  • PhageLab will also use the funding to expand its global team, which currently has close to 100 employees across Latin America and Europe.
  • Antibiotic-resistant outbreaks in livestock farming have been increasing, due to the high emergence rate of multidrug treatment-resistant bacteria.
  • The platform employs AI to generate “customized cocktails,” that can effectively manage pathogenic bacteria in the livestock industry and reduce antibiotic dependence.
  • PhageLab uses this library to create custom solutions in 45 days, that is safe and effective for use to eliminate livestock bacteria.

IDEXX Laboratories to Release 2023 Fourth Quarter and Full Year Financial Results

Retrieved on: 
Tuesday, January 23, 2024
Veterinary, Software, Pets, Health, Medical Devices, Health Technology, Technology, Consumer, Telephone, IDXX, Idexx Laboratories, Laboratory, Webcast

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2023 fourth quarter and full year financial results for Monday, February 5, 2024 before the market opens.

Key Points: 
  • IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2023 fourth quarter and full year financial results for Monday, February 5, 2024 before the market opens.
  • The Company will conduct an analyst conference call beginning at 8:30 a.m.
  • Individuals can access a live webcast of the conference call, transcript of prepared remarks, and the Q4 2023 Earnings Snapshot through a link on the IDEXX website, www.idexx.com/investors .
  • To listen to the live conference call, please dial 1-800-776-0420 or 1-773-377-9037 and reference passcode 764284.

ZIVO Bioscience Reports Positive Efficacy Results from 42-Day Validation Study with Non-Antibiotic Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens

Retrieved on: 
Tuesday, January 23, 2024
Biotechnology, Agriculture, Natural Resources, Health, Veterinary, Coccidiosis, Environment, Partnership, OTC, Poultry, Parity, Disease, USDA, Bird, Poultry farming

With these and earlier test results, ZIVO will pursue a partnership with a global animal health company for commercializing its coccidiosis product.

Key Points: 
  • With these and earlier test results, ZIVO will pursue a partnership with a global animal health company for commercializing its coccidiosis product.
  • The study design was similar to that of a previously successful 28-day challenge study but was extended through 42 days to replicate real-world conditions of the broiler production industry.
  • The results of the study in which the ZIVO treatment groups and a placebo control were blinded to the independent study contractor confirm previously reported positive effects of ZIVO’s non-antibiotic alternative for maintaining broiler health against coccidiosis.
  • Notably, the study also showed that the performance of ZIVO’s product candidate was comparable to that of a market leading anticoccidial product.